XBIT Xbiotech Inc.

-

Xbiotech Reported Earnings

Thursday, August 13, 2026 · 12:00 AM ET

Xbiotech (XBIT) reported a loss of $0.22 per share on revenue of $0.00 million for the . .

XBiotech Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing True Human(TM) monoclonal antibodies for treating diseases. XBiotech Inc. is based in AUSTIN, United States.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.22)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth-266.7 %
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth